NYSE:BTX Brooklyn ImmunoTherapeutics (BTX) Stock Price, News & Analysis $6.92 -0.01 (-0.14%) As of 11:04 AM Eastern Add Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendHeadlinesSEC FilingsTrendsBuy This Stock About Brooklyn ImmunoTherapeutics Stock (NYSE:BTX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BTX alerts:Sign Up Key Stats Today's Range$6.89▼$6.9450-Day Range$5.52▼$6.9252-Week Range$5.10▼$8.31Volume196,614 shsAverage Volume749,764 shsMarket Capitalization$407.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewEterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.Read More… Receive BTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address BTX Stock News HeadlinesBlackRock Announces Shareholder Approval of Strategy Changes to the BlackRock Technology and ...April 17, 2025 | gurufocus.comBrooklyn Nets News, Videos, Schedule, Roster, Stats - Yahoo SportsSeptember 15, 2024 | sports.yahoo.comElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.May 28, 2025 | Colonial Metals (Ad)'Brooklyn Nine-Nine' star Andre Braugher dies at 61December 19, 2023 | abcnews.go.comSabrina Carpenter blows off Catholic Church scandal: ‘Jesus was a carpenter’December 2, 2023 | nypost.comBrooklyn BridgeDecember 2, 2023 | travel.usnews.comBrooklyn Bedding Coupon for NovemberNovember 8, 2023 | time.comDozens of vendors still swarm Brooklyn Bridge in free-for-all — selling illegal cocktails, pics with live snake: photosSeptember 28, 2023 | nypost.comSee More Headlines BTX Stock Analysis - Frequently Asked Questions How have BTX shares performed this year? Brooklyn ImmunoTherapeutics' stock was trading at $0.2940 on January 1st, 2025. Since then, BTX stock has increased by 2,253.7% and is now trading at $6.92. View the best growth stocks for 2025 here. How do I buy shares of Brooklyn ImmunoTherapeutics? Shares of BTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Brooklyn ImmunoTherapeutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Brooklyn ImmunoTherapeutics investors own include Mastech Digital (MHH), Mastech Digital (MHH), Altimeter Growth Corp. 2 (AGCB), African Gold Acquisition (AGAC), Aldel Financial (ADF) and Adit EdTech Acquisition (ADEX). Company Calendar Record date for 3/31 Dividend3/14/2025Ex-Dividend for 3/31 Dividend3/14/2025Dividend Payable3/31/2025Today5/27/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry Television Broadcasting Sub-IndustryN/A Current SymbolNYSE:BTX CIK748592 WebN/A Phone(212) 582-1199FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$40.69 million Price / Sales10.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares58,826,000Free FloatN/AMarket Cap$407.08 million OptionableNo Data Beta4.61 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:BTX) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredDollar Collapse Warning: Protect Your Wealth NOWGlobal central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brooklyn ImmunoTherapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Brooklyn ImmunoTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.